DR MOUSA ,Optometrist

01/14/2024

01/14/2024

WAILEA, Hawaii — In this Healio video perspective, Mark L. Baum, chairman and CEO at Harrow, discusses the launch of Vevye ophthalmic solution for the treatment of dry eye disease, here at Hawaiian Eye 2024.

01/14/2024

WAILEA, Hawaii — Distinguishing between watery eyes and tearing eyes in patients is important for identifying destruction to the lacrimal system, according to a speaker here.

01/12/2024

NEW YORK — In a presentation at OSN New York, Sydney Tyson, MD, MPH, shares the story of a cyberattack his health care company experienced to help ophthalmologists prepare for the worst at their own practices.

01/12/2024

Vevye, a preservative-free, twice-daily 0.1% cyclosporine ophthalmic solution indicated for treatment of signs and symptoms of dry eye disease, is now available in the U.S., according to a manufacturer press release.“We are excited to see Vevye’s exceptional clinical trial data come to l...

01/12/2024

The first patient has been dosed in a phase 2 clinical trial investigating EYP-1901 for the treatment of diabetic macular edema, according to a press release from EyePoint Pharmaceuticals.

01/11/2024

The Advanced Research Projects Agency for Health has launched the Transplantation of Human Eye Allografts program, which aims to transplant whole human eyes to restore vision, according to a press release.

01/11/2024

The Tempo binocular perimeter significantly reduced visual field measurement time compared with the Humphrey field analyzer and was preferred by patients, according to a study published in Scientific Reports.“We hypothesized that this new technology could reduce testing duration and patient fa...

01/11/2024

Performance Vision Technologies has launched Altius advanced performance-tinted contact lenses, the second generation to Nike MaxSight, in the U.S. and select international markets.“The exceptional and unique potential of Altius in both elite and recreational athletes, combined with its role a...

01/11/2024

The FDA approved the VisuMax 800 femtosecond laser with SMILE pro software for the treatment of myopia with or without astigmatism, according to a press release from Carl Zeiss Meditec.

01/10/2024

ROME — A deep learning algorithm developed at University of California, Los Angeles, showed superior performance compared with other algorithms and human graders in detecting early biomarkers of age-related macular degeneration progression.

01/10/2024

Self-administered, remote virtual reality visual field testing can reliably monitor ocular disease in individuals with stable visual field defects, according to research published in the Journal of Glaucoma.“Remote, unsupervised monitoring of VFs in patients without ocular disease and those wi...

01/10/2024

NEW YORK — In a presentation at OSN New York, Shalesh Kaushal, MD, PhD, explains why he encourages ophthalmologists to consider using vitrectomy to treat vitreous floaters.

01/10/2024

OrCam Technologies unveiled new features that utilize artificial intelligence for its assistive devices, including an advanced AI companion for OrCam MyEye and a “Just Ask” feature for OrCam Read 3.“Advancements in AI are not merely a matter of technological evolution; they represe...

01/09/2024

Healio’s top retina items last year included the FDA approvals of Syfovre for geographic atrophy and Eylea HD for wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy.

01/09/2024

Artificial intelligence has potential to facilitate accurate, frequent and larger-scale home monitoring of chronic ocular diseases when safely integrated into workflows, according to a review published in Current Opinion in Ophthalmology.“Monitoring health conditions in the home environment is...

01/09/2024

Okyo Pharma announced positive safety and efficacy data from its phase 2 trial of OK-101 ophthalmic solution, a lipid-conjugated chemerin peptide agonist designed to reduce pain and inflammation in patients with dry eye disease.“It is remarkable that in this first-in-human study of OK-101 opht...